Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DOMO, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
74.5
109
142
173
210
258
309
319
317
319
Cost of revenue
33.2
44.9
49.6
55.9
56.7
67.1
73.1
75.5
81
79.7
Gross profit
41.3
63.6
92.9
117
153
191
236
244
236
239
Research and development
76.2
78.3
75.7
69.2
66.5
81
95.1
85
87.9
77.2
Selling and marketing
119
132
131
128
117
144
173
164
152
142
General and administrative
29.1
29.3
30.2
35.9
42.7
54.5
56
49.4
55.9
59.2
Operating expenses
224
239
237
233
227
279
324
298
295
278
Operating income
-183
-176
-144
-115
-73.1
-88.5
-88.9
-54.9
-59.3
-39.1
Other non-operating income
0.51
-0.4
-8.97
-9.64
-11.1
-14.1
-15.5
-19.4
-21.4
-18.5
Pre-tax income
-182
-176
-153
-125
-84.2
-103
-104
-74.3
-80.7
-57.6
Income tax
0.77
0.39
1.25
0.75
0.41
-0.46
1.18
1.26
1.21
1.76
Net income
-183
-177
-154
-126
-84.6
-102
-106
-75.6
-81.9
-59.3
EBITDA
-178
-168
-135
-108
-68.3
-83.1
-83.6
-48.3
-50
-29.3
EPS, basic
-124.90
-110.70
-9.43
-4.57
-2.89
-3.19
-3.10
-2.10
-2.13
-1.45
EPS, diluted
-124.90
-110.70
-9.43
-4.57
-2.89
-3.19
-3.10
-2.10
-2.13
-1.45
Shares, basic (weighted)
1.47
1.6
16.4
27.5
29.3
32
34.1
36.1
38.5
41
Shares, diluted (weighted)
1.47
1.6
16.4
27.5
29.3
32
34.1
36.1
38.5
41
Balance sheet
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
69
62
177
80.8
90.8
83.6
66.5
60.9
45.3
43
Short-term investments
0
18
0
Receivables
35.5
48.4
48
48.3
64.1
79
67.2
71.5
85.5
Other current assets
6.14
10.9
12.8
12.2
9.98
7.45
9.6
9.09
7.14
Total current assets
113
247
172
165
173
169
154
142
154
Property, plant and equipment
15
12.6
12.8
14.7
17.6
21.4
27
28.6
29
Lease right-of-use assets
3.66
16.4
15.3
11.7
10.2
11
Goodwill
9.48
9.48
9.48
9.48
9.48
9.48
9.48
9.48
9.48
Intangible assets
3.03
4.42
3.87
3.36
2.88
2.79
2.74
2.13
1.56
Other non-current assets
3.12
1.36
1.23
1.42
1.98
2.1
1.41
2.72
2.59
Total assets
155
293
217
216
245
242
226
214
236
Accounts payable
12.1
2.61
2.3
1.09
4.77
12.1
4.31
10
18.8
Accrued liabilities
49.4
48.1
46.5
52
60
49.3
43.4
49.7
60.9
Deferred revenue
66.7
89
105
129
168
182
185
178
175
Short-term debt
0
Total current liabilities
128
140
154
186
237
249
238
255
271
Long-term debt
46.3
97.2
101
99.6
104
109
114
118
126
Lease liabilities
1.56
16.8
15.3
11.1
7.7
5.68
Other non-current liabilities
5.32
6.21
6.33
9.64
10.9
12.4
14
8.45
12.2
Total liabilities
184
248
266
300
371
389
379
392
422
Total debt
46.3
97.2
101
99.6
104
109
114
118
126
Paid-in capital
35.3
956
988
1,038
1,098
1,184
1,252
1,311
1,360
Retained earnings
-758
-912
-1,038
-1,122
-1,224
-1,330
-1,406
-1,488
-1,547
Other comprehensive income
0.51
0.44
0.39
0.88
0.39
-0.32
-0.18
-0.67
1.12
Shareholders' equity
-556
-722
44.5
-49.2
-83.5
-126
-146
-154
-177
-186
Total equity
-556
-722
44.5
-49.2
-83.5
-126
-146
-154
-177
-186
Total liabilities and equity
155
293
217
216
245
242
226
214
236
Cash flow statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-183
-177
-154
-126
-84.6
-102
-106
-75.6
-81.9
-59.3
Depreciation and amortization
4.9
8.13
8.79
6.92
4.77
5.36
5.29
6.62
9.24
9.84
Stock-based compensation
9.34
9.37
21.8
23.8
33.7
60.5
83.9
64.3
59.4
56.1
Deferred income tax
0.24
0.15
0.1
-0.01
0.02
Change in receivables
-2.8
-13.2
-12.9
0.45
-0.31
-15.9
-14.8
11.8
-4.35
-13.9
Change in payables
4.54
3.25
-8.65
-0.29
-1.34
3.76
6.95
-6.97
1.83
8.88
Cash from operations
-144
-149
-131
-80.2
-15.9
0.38
-10.9
2.58
-9.05
7.93
Capital expenditures
-11.6
-7.28
-6.37
-6.47
-5.71
-6.52
-8
-11.7
-9.45
-9.95
Purchases of investments
0
0
-102
-11.1
0
0
Cash from investing
-12.1
-7.6
-7.98
-23.8
12.2
-6.52
-8
-11.8
-9.45
-9.95
Stock issued
0.75
0
0
7.81
6.75
4.13
1.56
3.41
1.91
1.33
Share buybacks
0
-0.12
0
0
Cash from financing
-3.47
149
254
7.98
13.1
-0.56
2.42
3.47
3.39
-2.2
Exchange rate effect
0.12
0.14
0.01
-0.08
0.49
-0.53
-0.6
0.15
-0.57
1.91
Net change in cash
-160
-7.01
115
-96.1
9.95
-7.23
-17.1
-5.56
-15.7
-2.31
Free cash flow
-156
-156
-138
-86.7
-21.6
-6.14
-18.9
-9.15
-18.5
-2.02
Interest paid
0.03
0.31
6.9
9.08
7.59
7.14
9.11
12.6
12.1
9.97
Income taxes paid
0.21
0.5
0.82
0.37
0.84
0.63
0.31
0.58
1.17
-0.03
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $3.55 on September 23, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
75.4%
Gross profit / revenue.
Operating margin
-9.8%
Operating income / revenue.
Pre-tax margin
-12.8%
Pre-tax income / revenue.
Net margin
-13.4%
Net income / revenue.
FCF margin
-2.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.2%
Cash from operations / revenue.
Return on assets (ROA)
-24.1%
Net income / average total assets.
R&D / revenue
23.7%
Research and development expense / revenue.
Stock-based pay / revenue
16.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.6%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
0.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
1.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
8.7%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
1.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
0.5%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
9.3%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
9.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-0.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
1.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
6.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
6.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
6.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.28x
Current assets / current liabilities.
Quick ratio
0.21x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.07x
(Cash + short-term investments) / current liabilities.
Debt / assets
78.4%
Total debt / total assets.
Liabilities / assets
207.1%
Total liabilities / total assets.
Net debt
$112.2M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$6.85
Revenue / diluted weighted shares.
FCF per share
-$0.19
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$4.07
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.51x
Market cap / revenue.
EV/Sales
0.86x
Enterprise value / revenue.
FCF yield
-5.5%
Free cash flow / market cap.
Earnings yield
-26.3%
Net income / market cap (the inverse of P/E).
What was DOMO, INC.'s revenue in fiscal 2026?
DOMO, INC. reported revenue of $318.9M for fiscal 2026, 0.6% higher than the year before.
Was DOMO, INC. profitable in fiscal 2026?
No. It reported a net loss of $59.3M.
How much free cash flow did DOMO, INC. generate in fiscal 2026?
Cash from operations of $7.9M minus capital expenditures of $10.0M left free cash flow of -$2.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.